Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Launches Study For Diagnosis Of Peripheral Lung Nodules

June 24 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES ANNOUNCES THE LAUNCH OF A FIRST IN
HUMAN
STUDY COMBINING ROBOTIC NAVIGATIONAL BRONCHOSCOPY AND
NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY
    * STUDY WILL BE CO-FUNDED BY LUNG CANCER INITIATIVE AT
JOHNSON &
JOHNSON AND MAUNA KEA TECHNOLOGIES
    * RECEIVED AUTHORIZATION FROM FCCC IRB TO START PILOT
CLINICAL
STUDY FOR DIAGNOSIS OF PERIPHERAL LUNG NODULES

Source text for Eikon:  ID:nBwDS2YKa 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Mauna Kea Technologies SA

See all news